Literature DB >> 12198765

Correlation between extent of osteolytic damage and metastatic burden of human breast cancer metastasis in nude mice: real-time PCR quantitation.

Angus M Tester1, Julie A Sharp, Nirada Dhanesuan, Mark Waltham, Erik W Thompson.   

Abstract

Orthotopic or intracardiac injection of human breast cancer cell lines into immunocompromised mice allows study of the molecular basis of breast cancer metastasis. We have established a quantitative real-time PCR approach to analyze metastatic spread of human breast cancer cells inoculated into nude mice via these routes. We employed MDA-MB-231 human breast cancer cells genetically tagged with a bacterial beta-galactosidase (Lac-Z) retroviral vector, enabling their detection by TaqMan real-time PCR. PCR detection was linear, specific, more sensitive than conventional PCR, and could be used to directly quantitative metastatic burden in bone and soft organs. Attesting to the sensitivity and specificity of the PCR detection strategy, as few as several hundred metastatic MDA-MB-231 cells were detectable in 100 microns segments of paraffin-embedded lung tissue, and only in samples adjacent to sections that scored positive by histological detection. Moreover, the measured real-time PCR metastatic burden in the bone environment (mouse hind-limbs, n = 48) displayed a high correlation to the degree of osteolytic damage observed by high resolution X-ray analysis (r2 = 0.972). Such a direct linear relationship to tumor burden and bone damage substantiates the so-called 'vicious cycle' hypothesis in which metastatic tumor cells promote the release of factors from the bone which continue to stimulate the tumor cells. The technique provides a useful tool for molecular and cellular analysis of human breast cancer metastasis to bone and soft organs, can easily be extended to other cell/marker/organ systems, and should also find application in preclinical assessment of anti-metastatic modalities.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12198765     DOI: 10.1023/a:1016381416463

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  21 in total

Review 1.  Recent advances in the polymerase chain reaction.

Authors:  H A Erlich; D Gelfand; J J Sninsky
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

2.  Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.

Authors:  L Pederson; B Winding; N T Foged; T C Spelsberg; M J Oursler
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

3.  Breast cancer cells interact with osteoblasts to support osteoclast formation.

Authors:  R J Thomas; T A Guise; J J Yin; J Elliott; N J Horwood; T J Martin; M T Gillespie
Journal:  Endocrinology       Date:  1999-10       Impact factor: 4.736

4.  Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.

Authors:  T Yoneda; A Sasaki; C Dunstan; P J Williams; F Bauss; Y A De Clerck; G R Mundy
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

Review 5.  Cellular and molecular basis of preferential metastasis of breast cancer to bone.

Authors:  T Yoneda
Journal:  J Orthop Sci       Date:  2000       Impact factor: 1.601

6.  Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysis.

Authors:  D R Clohisy; D Palkert; M L Ramnaraine; I Pekurovsky; M J Oursler
Journal:  J Orthop Res       Date:  1996-05       Impact factor: 3.494

7.  Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice.

Authors:  J E Price; A Polyzos; R D Zhang; L M Daniels
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

8.  lacZ transduced human breast cancer xenografts as an in vivo model for the study of invasion and metastasis.

Authors:  N Brünner; E W Thompson; M Spang-Thomsen; J Rygaard; K Danø; J A Zwiebel
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

Review 9.  Transfected MCF-7 cells as a model for breast-cancer progression.

Authors:  F G Kern; S W McLeskey; L Zhang; J Kurebayashi; Y Liu; I Y Ding; S Kharbanda; D Chen; D Miller; K Cullen
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

10.  Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells.

Authors:  M B Crichton; J E Nichols; Y Zhao; S E Bulun; E R Simpson
Journal:  Mol Cell Endocrinol       Date:  1996-04-19       Impact factor: 4.102

View more
  5 in total

1.  Oncolytic adenovirus expressing soluble TGFβ receptor II-Fc-mediated inhibition of established bone metastases: a safe and effective systemic therapeutic approach for breast cancer.

Authors:  Zebin Hu; Helen Gerseny; Zhenwei Zhang; Yun-Ju Chen; Arthur Berg; Zhiling Zhang; Stuart Stock; Prem Seth
Journal:  Mol Ther       Date:  2011-06-28       Impact factor: 11.454

2.  Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice.

Authors:  Julie A Sharp; Mark Waltham; Elizabeth D Williams; Michael A Henderson; Erik W Thompson
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

3.  Inhibition of breast cancer cell adhesion and bone metastasis by the extracellular adherence protein of Staphylococcus aureus.

Authors:  Darius Schneider; Lucy Liaw; Carolin Daniel; Athanasios N Athanasopoulos; Mathias Herrmann; Klaus T Preissner; Peter P Nawroth; Triantafyllos Chavakis
Journal:  Biochem Biophys Res Commun       Date:  2007-04-02       Impact factor: 3.575

4.  An MMP13-selective inhibitor delays primary tumor growth and the onset of tumor-associated osteolytic lesions in experimental models of breast cancer.

Authors:  Manisha Shah; Dexing Huang; Tony Blick; Andrea Connor; Lawrence A Reiter; Joel R Hardink; Conor C Lynch; Mark Waltham; Erik W Thompson
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

5.  An inter-platform repeatability study investigating real-time amplification of plasmid DNA.

Authors:  Carol E Donald; Fizza Qureshi; Malcolm J Burns; Marcia J Holden; Joseph R Blasic; Alison J Woolford
Journal:  BMC Biotechnol       Date:  2005-05-25       Impact factor: 2.563

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.